We are live on ! Find out more
TBI

Trueblue

111 hedge funds and large institutions have $174M invested in Trueblue in 2025 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 39 increasing their positions, 44 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

8,600% more call options, than puts

Call options by funds: $261K | Put options by funds: $3K

19% more capital invested

Capital invested by funds: $146M → $174M (+$28.4M)

0% more funds holding

Funds holding: 111111 (0)

0% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 17

2.41% less ownership

Funds ownership: 92.38%89.97% (-2.4%)

11% less repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 44

Holders
111
Holders Change
Holders Change %
0%
% of All Funds
1.46%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
17
Increased
39
Reduced
44
Closed
17
Calls
$261K
Puts
$3K
Net Calls
+$258K
Net Calls Change
+$232K

TBI Hedge Fund Activity: Q2 2025 in Review

111 of the 7,613 institutional investors tracked by Wall St. Rank reported a position in Trueblue (TBI) for Q2 2025, worth a combined $174M — up 19% from $146M a quarter earlier.

Fund positioning in TBI was balanced in Q2 2025: 17 funds opened new positions, 17 closed out, 39 added to existing stakes and 44 trimmed.

The largest buyer was Boston Partners, adding an estimated $3.97M. The largest seller was Fidelity Investments, cutting an estimated $9.57M.

  • 111 institutional investors held Trueblue (TBI) as of Q2 2025, unchanged from Q1 2025.
  • Funds reported $174M of Trueblue stock for Q2 2025, up 19% quarter-over-quarter.
  • 17 funds opened new Trueblue positions in Q2 2025 and 17 closed out, a net change of 0 holders.
  • The largest Trueblue buyer in Q2 2025 was Boston Partners, an estimated $3.97M added.
  • The largest Trueblue seller in Q2 2025 was Fidelity Investments, an estimated $9.57M sold.

Based on aggregated 13F filings for Q2 2025.